114 related articles for article (PubMed ID: 7609288)
1. [Effects of thromboxane on pulmonary arterial response to platelet activating factor in rabbit].
Enzan K; Komatsu H; Shoji K; Suzuki M
Masui; 1995 May; 44(5):633-42. PubMed ID: 7609288
[TBL] [Abstract][Full Text] [Related]
2. Thromboxane rather than platelet activating factor mediates pulmonary vasoconstriction after antigen challenge in rabbits.
Enzan K; Kurosawa S; Yoshioka N; Inaba H
Shock; 1996 Sep; 6(3):183-7. PubMed ID: 8885083
[TBL] [Abstract][Full Text] [Related]
3. [Effects of thromboxane A2 receptor antagonist, KT2-962 on pulmonary hypertensive responses to antigen challenge in isolated sensitized rabbit lung].
Shoji K; Enzan K; Masaki Y; Suzuki M; Yoshioka N
Masui; 1995 Jan; 44(1):21-5. PubMed ID: 7699820
[TBL] [Abstract][Full Text] [Related]
4. [The role of thromboxane A2 in the development of airway responsiveness after platelet activating factor inhalation in dogs].
Imai T; Adachi M; Idaira K; Hiyama T; Suganuma T; Takahashi T; Saito C; Maeda M; Tsuji A
Arerugi; 1991 Jan; 40(1):37-45. PubMed ID: 2029218
[TBL] [Abstract][Full Text] [Related]
5. Platelet-activating factor and bacteremia-induced pulmonary hypertension.
Clavijo LC; Carter MB; Matheson PJ; Wills-Frank LA; Wilson MA; Wead WB; Garrison RN
J Surg Res; 2000 Feb; 88(2):173-80. PubMed ID: 10644485
[TBL] [Abstract][Full Text] [Related]
6. [Effect of BAY u3405-thromboxane A2 receptor antagonist, on biphasic airway responses induced by platelet-activating factor in actively sensitized guinea pigs].
Arima M; Yukawa T; Fukuda T; Makino S
Arerugi; 1995 Jul; 44(7):701-7. PubMed ID: 7575136
[TBL] [Abstract][Full Text] [Related]
7. [Effects of platelet activating factor (PAF:AGEPC) on airway and pulmonary vascular constriction of guinea pigs--with special reference to the relation with TXA2].
Hamasaki Y; Said SI; Tai HH
Kokyu To Junkan; 1983 Jul; 31(7):755-61. PubMed ID: 6658209
[No Abstract] [Full Text] [Related]
8. Effect of systemic platelet-activating factor (PAF) on the rabbit spinal cord microcirculation.
Lindsberg PJ; Jacobs TP; Paakkari IA; Hallenbeck JM; Feuerstein G
J Lipid Mediat; 1990; 2(1):41-58. PubMed ID: 2133267
[TBL] [Abstract][Full Text] [Related]
9. Thromboxane mediation of pulmonary hemodynamic responses after neutralization of heparin by protamine in pigs.
Conzen PF; Habazettl H; Gutmann R; Hobbhahn J; Goetz AE; Peter K; Brendel W
Anesth Analg; 1989 Jan; 68(1):25-31. PubMed ID: 2910134
[TBL] [Abstract][Full Text] [Related]
10. Role of thromboxane A2 and platelet activating factor in early haemodynamic response to lipopolysaccharide in rats.
Bocheński J; Chłopicki S; Gryglewski RJ
J Physiol Pharmacol; 1999 Jun; 50(2):287-97. PubMed ID: 10424723
[TBL] [Abstract][Full Text] [Related]
11. [Effect of platelet activating factor on TxA2, PGI2 and Ca(2+)-ATPase activity in the intra-pulmonary artery smooth muscle cells].
Hu DH; Ma CT
Sheng Li Xue Bao; 1996 Aug; 48(4):343-7. PubMed ID: 9389196
[TBL] [Abstract][Full Text] [Related]
12. Administration of chronic intravenous platelet-activating factor induces pulmonary arterial atrophy and hypertension in rabbits.
Ohar JA; Waller KS; DeMello D; Lagunoff D
Lab Invest; 1991 Oct; 65(4):451-8. PubMed ID: 1833589
[TBL] [Abstract][Full Text] [Related]
13. Role of thromboxane A2 in airway microvascular leakage induced by inhaled platelet-activating factor.
Tokuyama K; Lötvall JO; Morikawa A; Barnes PJ; Chung KF
J Appl Physiol (1985); 1991 Nov; 71(5):1729-34. PubMed ID: 1837014
[TBL] [Abstract][Full Text] [Related]
14. Role of paf-acether in protamine-induced thrombocytopenia in rabbits.
Nathan N; Aissa J; Benveniste J; Arnoux B
Eur J Anaesthesiol; 1992 Jul; 9(4):347-52. PubMed ID: 1628640
[TBL] [Abstract][Full Text] [Related]
15. Effects of platelet-activating factor, thromboxane A2 and leukotriene D4 on isolated perfused rat liver.
Cui S; Shibamoto T; Liu W; Takano H; Kurata Y
Prostaglandins Other Lipid Mediat; 2006 Jul; 80(1-2):35-45. PubMed ID: 16846785
[TBL] [Abstract][Full Text] [Related]
16. A rabbit model of pulmonary hypertension induced by the synthetic platelet-activating factor acetylglyceryl ether phosphorylcholine.
Ohar JA; Pyle JA; Waller KS; Hyers TM; Webster RO; Lagunoff D
Am Rev Respir Dis; 1990 Jan; 141(1):104-10. PubMed ID: 2297169
[TBL] [Abstract][Full Text] [Related]
17. [Involvement of platelet activating factors in pathologic leukocyte-endothelium interactions in the liver after hemorrhagic shock].
Marzi I; Bauer M; Reisdorf E; Walcher F
Zentralbl Chir; 1994; 119(11):814-21. PubMed ID: 7846961
[TBL] [Abstract][Full Text] [Related]
18. Thromboxane mediates the renal hemodynamic effects of platelet activating factor.
Yoo J; Schlondorff D; Neugarten J
J Pharmacol Exp Ther; 1990 May; 253(2):743-8. PubMed ID: 2140130
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of antigen-induced airway hyperresponsiveness in rats: effects of ozagrel (a thromboxane A2 synthase inhibitor) and of CV-3988 (a platelet activating factor antagonist).
Misawa M; Chiba Y
Res Commun Chem Pathol Pharmacol; 1994 Jun; 84(3):341-9. PubMed ID: 7938906
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular responses to exogenous platelet-activating factor (PAF) in anesthetized ponies, and the effects of a PAF antagonist, WEB 2086.
Wilson DV; Eberhart SW; Robinson NE; Rice R; Gray PR
Am J Vet Res; 1993 Feb; 54(2):274-9. PubMed ID: 8430938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
